ID

18401

Descripción

Adjuvant Cisplatin and Docetaxel in Non Small Cell Lung Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00582634

Link

https://clinicaltrials.gov/show/NCT00582634

Palabras clave

  1. 3/11/16 3/11/16 -
Subido en

3 de noviembre de 2016

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY 4.0

Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Eligibility Non Small Cell Lung Cancer NCT00582634

Eligibility Non Small Cell Lung Cancer NCT00582634

Inclusion Criteria
Descripción

Inclusion Criteria

Alias
UMLS CUI
C1512693
stage ib to iiia non-small cell lung cancer completely resected within 4 to 8 weeks of initiating treatment on study
Descripción

Non-Small Cell Lung Carcinoma Complete excision | TNM clinical staging

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0007131
UMLS CUI [1,2]
C0015250
UMLS CUI [2]
C3258246
performance status ecog 0 or 1
Descripción

ECOG performance status

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1520224
peripheral neuropathy: < grade 1
Descripción

Peripheral Neuropathy | CTCAE Grades

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0031117
UMLS CUI [2]
C1516728
adequate blood cell counts
Descripción

Blood Cell Count

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0005771
adequate liver and hepatic function
Descripción

Liver function | Renal function

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0232741
UMLS CUI [2]
C0232804
women of childbearing potential must have a negative pregnancy test.
Descripción

Childbearing Potential Pregnancy test negative

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C3831118
UMLS CUI [1,2]
C0427780
men and women of childbearing potential must be willing to consent to using effective contraception while on treatment and for at least 3 months thereafter
Descripción

Fertility Contraceptive methods

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0015895
UMLS CUI [1,2]
C0700589
Exclusion Criteria
Descripción

Exclusion Criteria

Alias
UMLS CUI
C0680251
patients with a history of severe hypersensitivity reaction to docetaxel® or other drugs formulated with polysorbate 80.
Descripción

severe allergy docetaxel | severe allergy Pharmaceutical Preparations Polysorbate 80 Based

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C2945656
UMLS CUI [1,2]
C0246415
UMLS CUI [2,1]
C2945656
UMLS CUI [2,2]
C0013227
UMLS CUI [2,3]
C0032601
UMLS CUI [2,4]
C1705938
women who are breast-feeding.
Descripción

Breast Feeding

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0006147
coexistent second malignancy or history of prior malignancy within previous 5 years (excluding basal or squamous cell carcinoma of the skin that has been treated curatively)
Descripción

Neoplasms, Second Primary | Malignant Neoplasm Previous | Basal cell carcinoma Curative treatment | Squamous cell carcinoma of skin Curative treatment

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0085183
UMLS CUI [2,1]
C0006826
UMLS CUI [2,2]
C0205156
UMLS CUI [3,1]
C0007117
UMLS CUI [3,2]
C1273390
UMLS CUI [4,1]
C0553723
UMLS CUI [4,2]
C1273390
uncontrolled cardiac disease or uncontrolled hypertension
Descripción

Heart Disease Uncontrolled | Uncontrolled hypertension

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0018799
UMLS CUI [1,2]
C0205318
UMLS CUI [2]
C1868885

Similar models

Eligibility Non Small Cell Lung Cancer NCT00582634

Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
C1512693 (UMLS CUI)
Non-Small Cell Lung Carcinoma Complete excision | TNM clinical staging
Item
stage ib to iiia non-small cell lung cancer completely resected within 4 to 8 weeks of initiating treatment on study
boolean
C0007131 (UMLS CUI [1,1])
C0015250 (UMLS CUI [1,2])
C3258246 (UMLS CUI [2])
ECOG performance status
Item
performance status ecog 0 or 1
boolean
C1520224 (UMLS CUI [1])
Peripheral Neuropathy | CTCAE Grades
Item
peripheral neuropathy: < grade 1
boolean
C0031117 (UMLS CUI [1])
C1516728 (UMLS CUI [2])
Blood Cell Count
Item
adequate blood cell counts
boolean
C0005771 (UMLS CUI [1])
Liver function | Renal function
Item
adequate liver and hepatic function
boolean
C0232741 (UMLS CUI [1])
C0232804 (UMLS CUI [2])
Childbearing Potential Pregnancy test negative
Item
women of childbearing potential must have a negative pregnancy test.
boolean
C3831118 (UMLS CUI [1,1])
C0427780 (UMLS CUI [1,2])
Fertility Contraceptive methods
Item
men and women of childbearing potential must be willing to consent to using effective contraception while on treatment and for at least 3 months thereafter
boolean
C0015895 (UMLS CUI [1,1])
C0700589 (UMLS CUI [1,2])
Item Group
C0680251 (UMLS CUI)
severe allergy docetaxel | severe allergy Pharmaceutical Preparations Polysorbate 80 Based
Item
patients with a history of severe hypersensitivity reaction to docetaxel® or other drugs formulated with polysorbate 80.
boolean
C2945656 (UMLS CUI [1,1])
C0246415 (UMLS CUI [1,2])
C2945656 (UMLS CUI [2,1])
C0013227 (UMLS CUI [2,2])
C0032601 (UMLS CUI [2,3])
C1705938 (UMLS CUI [2,4])
Breast Feeding
Item
women who are breast-feeding.
boolean
C0006147 (UMLS CUI [1])
Neoplasms, Second Primary | Malignant Neoplasm Previous | Basal cell carcinoma Curative treatment | Squamous cell carcinoma of skin Curative treatment
Item
coexistent second malignancy or history of prior malignancy within previous 5 years (excluding basal or squamous cell carcinoma of the skin that has been treated curatively)
boolean
C0085183 (UMLS CUI [1])
C0006826 (UMLS CUI [2,1])
C0205156 (UMLS CUI [2,2])
C0007117 (UMLS CUI [3,1])
C1273390 (UMLS CUI [3,2])
C0553723 (UMLS CUI [4,1])
C1273390 (UMLS CUI [4,2])
Heart Disease Uncontrolled | Uncontrolled hypertension
Item
uncontrolled cardiac disease or uncontrolled hypertension
boolean
C0018799 (UMLS CUI [1,1])
C0205318 (UMLS CUI [1,2])
C1868885 (UMLS CUI [2])

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial